News & Events

In the News

Headlines featuring UW Biostatistics people and research.
Quinn White
Quinn White
MESA heart disease risk score worked well with or without race included
American Heart Association Newsroom,

“Our work is part of a growing effort to assess the implications of including race and ethnicity in clinical risk prediction models,” said lead investigator Quinn White, a biostatistics doctoral student at the University of Washington, Seattle.

Michael LeBlanc
Michael LeBlanc
Longer-term data from SWOG S1826 trial confirm nivolumab-AVD benefit in Hodgkin lymphoma
SWOG Cancer Research Network,

Two years after starting treatment, patients with stage 3-4 classic Hodgkin lymphoma treated with nivolumab plus AVD chemotherapy had roughly one-half the risk of progression or death of those who had a standard treatment of brentuximab vedotin plus AVD. 

“This new analysis with more patient follow-up is critical to understanding the clinically meaningful benefit obtained from N-AVD compared to BV-AVD,” said Michael LeBlanc, PhD, lead biostatistician on the S1826 study and a UW professor of biostatistics.

Photo of Lianne Sheppard sitting on a bench
Photo of Lianne Sheppard sitting on a bench
Get to know new interim DEOHS Chair Lianne Sheppard
Department of Environmental and Occupational Health Sciences,

Lianne Sheppard, new DEOHS interim chair, looks to build community, support faculty as she steps into new role. Sheppard is also a professor of biostatistics.

Kenneth Rice
Kenneth Rice
PRIMED Consortium Advances Polygenic Risk Scores For Diverse Groups
genomeweb,

An international consortium founded to develop and evaluate methods to improve the use of polygenic risk scores (PRS) for predicting disease and health outcomes in populations of diverse ancestry has recently found some benefit in applying them to cardiovascular disease and type 2 diabetes. Ken Rice, principal investigator of the consortium's coordinating center at the University of Washington and professor of biostatistics, is quoted.

Photo of man pointing thumbs down
Photo of man pointing thumbs down
HIV Vaccine Candidates Fail to Reduce Infections
Precision Vaccinations,

Dr. Peter Gilbert shares insights about his work with HIV vaccine efficacy trials in relation to the recent PrEPVacc study. Gilbert said, "The result was that, for each vaccine, there is close to a 50-50 chance that the vaccine elevated acquisition risk vs. the vaccine was safe, as a synthesis of results over multiple ways to do the analysis, most importantly considering different prior distributions for vaccine efficacy."

Garnet Anderson
Garnet Anderson
36 new members elected to Washington State Academy of Sciences
Washington State Academy of Sciences,

Congratulations to Garnet Anderson (PhD ’89), senior vice president and director of the Public Health Sciences Division at the Fred Hutchinson Cancer Center and an affiliate professor of biostatistics at the UW School of Public Health, who was one of 36 scientists named to the Washington State Academy of Life Sciences. 

R Yates Coley
R Yates Coley
Health Care Heroes: Yates Coley
Puget Sound Business Journal,

"As a biostatistician, I get to bring my quantitative and critical thinking skills to wide range of problems." Congratulations to Yates Coley, PhD, on their 2024 Health Care Heroes award from the Puget Sound Business Journal.

Headshots of Anderson, Etzioni, Feng, and Kooperberg
Headshots of Anderson, Etzioni, Feng, and Kooperberg
2024 Cancer Health 25: People Who Power Clinical Trials
Cancer Health,

Fred Hutch researchers and UW Biostatistics faculty are recognized by Cancer Health as People Who Power Clinical Trials.